Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
Nature Communications|October 10, 2019
One-shot preparation of topologically chimeric nanofibers via a gradient supramolecular copolymerizationYuichi Kitamoto, Ziyan Pan, Deepak D Prabhu, et al.
Bioengineering (Basel, Switzerland)|March 28, 2026
The Extracellular Matrix in Liver Regeneration: Biological and Therapeutic InsightsHaodong Ma, Wenyue Wu, Wen Zhang, et al.
Clinical and Molecular Hepatology|May 25, 2017
Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysisOidov Baatarkhuu, Hye Won Lee, Jacob George, et al.
Journal of Clinical Gastroenterology|June 6, 2012
Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4Mahmoud Aboelneen Khattab, Mohammed Eslam, Mayada M Aly, et al.
Vaccines|June 24, 2022
COVID-19 Impact on Australian Patients with Substance Use Disorders: Emergency Department Admissions in Western Sydney before Vaccine Roll OutMeryem Jefferies, Harunor Rashid, Robert Graham, et al.
International Journal of Molecular Sciences|June 2, 2021
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective StudyShuhei Fukunaga, Dan Nakano, Takumi Kawaguchi, et al.
Annals of Hepatology|January 1, 2014
Diabetes worsening of hepatitis C cirrhosis: are alterations in monocytic tissue factor (CD 142) is the cause?Mona A Abu El Makarem, Mohammed Eslam, Douaa Sayed, et al.
Genes|October 28, 2023
Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort StudyShreya C Pal, Stephany M Castillo-Castañeda, Luis E Díaz-Orozco, et al.
Biochemical Pharmacology|March 7, 2026
miR-454-3p drives development of hepatic steatosis by negatively regulating JARID2Ting Zhang, Ziyan Pan, Lijun Fan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2016
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver diseaseKonstantin Kazankov, Francisco Barrera, Holger Jon Møller, et al.
Pageof 18